Cardiac
-
Permission granted by Versa Vascular
Medtronic veteran departs for CEO role at heart valve startup
Bill Shields, who led transcatheter mitral and tricuspid therapies at Medtronic, has joined Versa Vascular, developer of a valve repair treatment.
By Susan Kelly • Aug. 12, 2026 -
Courtesy of VitalConnect
IRhythm grows heart monitoring leadership with $288M VitalConnect buy
Acquiring VitalConnect could unlock a $1 billion cardiac monitoring market that is only partly served by iRhythm’s existing devices.
By Nick Paul Taylor • Aug. 10, 2026 -
Explore the Trendline➔
Courtesy of Johnson & Johnson
TrendlineNew medical devices are reshaping the medtech industry
From pulsed field ablation devices to glucose sensors and surgical robotics, new medical technologies are transforming patient care and how people manage their health.
By MedTech Dive staff -
Patrik Stollarz / Staff via Getty Images
Philips forms 6 patient monitoring partnerships
By employing wearable devices to support patient monitoring between the hospital and home, Philips hopes to improve care continuity.
By Nick Paul Taylor • Aug. 7, 2026 -
Courtesy of Medtronic
Medtronic gets CE mark for ablation to treat ventricular tachycardia
Older ablation approaches for ventricular tachycardia have been suboptimal, Medtronic said. The company plans to bring a more effective treatment for the life-threatening heart condition.
By Susan Kelly • Aug. 7, 2026 -
Permission granted by Caristo Diagnostics
Caristo wins FDA authorization for cardiovascular risk predictor
The University of Oxford spinout will soon launch the AI tool, which research suggests could help assess heart attack risk in patients who don’t have obstructive coronary artery disease.
By Nick Paul Taylor • Aug. 4, 2026 -
Courtesy of Siemens Healthineers
Siemens Healthineers, Cleveland Clinic form 10-year alliance
The deal to provide a range of imaging and therapeutic technologies to Cleveland Clinic extends the partners’ longtime relationship and follows a recent 10-year pact between Siemens Healthineers and Mayo Clinic.
By Nick Paul Taylor • July 31, 2026 -
Sinhyu via Getty Images
Medtronic leads $37M investment in ablation mapping startup CoreMap
Medtronic has backed CoreMap to address a critical unmet need in atrial fibrillation treatment.
By Nick Paul Taylor • July 30, 2026 -
Permission granted by Abbott
Abbott starts TriClip study amid rising competition for heart valve repair
Facing competition from Edwards, Abbott is studying TriClip’s real-world safety and performance in about 1,000 patients.
By Nick Paul Taylor • July 29, 2026 -
Courtesy of Boston Scientific
Boston Scientific to restructure, taking up to $800M in charges
The plan involves transferring production lines and cutting jobs, following a slowdown in two of the company’s key product lines.
By Elise Reuter • July 28, 2026 -
Courtesy of Edwards Lifesciences
Edwards posts strong TAVR sales ahead of potential Medicare coverage expansion
An upcoming Medicare coverage decision for transcatheter aortic valve replacement devices and study readout for patients with moderate disease are expected to help the company maintain its momentum.
By Susan Kelly • July 24, 2026 -
Stringer via Getty Images
GE HealthCare inks 10-year, $500M alliance with Catholic Health
The deal is the latest in a series of pacts that GE HealthCare has made with health systems, including with Sutter Health and UC San Diego.
By Nick Paul Taylor • July 21, 2026 -
hapabapa via Getty Images
Edwards will pay $10M to settle FTC charges of skirting antitrust review
The artificial heart valve maker will settle allegations it deliberately structured its deal to acquire JC Medical to sidestep a Hart-Scott-Rodino review.
By Susan Kelly • July 13, 2026 -
Courtesy of Johnson & Johnson
J&J wins FDA approval for dual-energy ablation catheter
Johnson & Johnson expects U.S. physicians to perform the first procedures with the device this summer as it starts a phased commercial rollout.
By Nick Paul Taylor • July 9, 2026 -
Getty Images
Penumbra starts trial of clot removal device in stroke subgroup
Penumbra, which is set to become part of Boston Scientific this year, is running the trial to inform the treatment of a type of medium-vessel blockage.
By Nick Paul Taylor • July 8, 2026 -
Courtesy of Boston Scientific
Top 10 medtech deals in the first half of 2026
Boston Scientific, Medtronic and Stryker were among the companies to ink deals to move into markets that are expanding quickly.
By Nick Paul Taylor • July 6, 2026 -
Getty Images
Terumo recalls stent-graft system linked to three deaths
Terumo has yet to establish a direct causal relationship between the deaths and the delivery system separation issues.
By Nick Paul Taylor • July 2, 2026 -
Courtesy of Edwards Lifesciences
Edwards wins FDA clearance for LAA clip, setting up competition with AtriCure and Medtronic
Edwards Lifesciences is expected to introduce the new device to surgical heart valve customers this year in a “measured, targeted rollout,” one analyst said.
By Susan Kelly • June 29, 2026 -
Permission granted by ShockWave
J&J starts pivotal trials of Shockwave IVL device in carotid arteries
J&J is working to expand use of Shockwave’s technology as competition in intravascular lithotripsy builds from companies like Boston Scientific and Stryker.
By Nick Paul Taylor • June 29, 2026 -
Permission granted by Johnson & Johnson
FDA posts early alert over device used with Impella heart pumps
J&J’s Abiomed and manufacturing partner Oscor warned of a bleeding risk from devices used to introduce catheters to the body.
By Nick Paul Taylor • June 22, 2026 -
Getty Images
Penumbra wins CE mark for Thunderbolt clot removal tech
The international launch could benefit from Boston Scientific’s global footprint when the company closes its takeover of Penumbra.
By Nick Paul Taylor • June 18, 2026 -
Courtesy of Boston Scientific
Medtech M&A maintains momentum following decade-high 2025: PwC
Deal volumes and values are tracking above the first half of 2025, driven by Boston Scientific’s Penumbra buyout and Danaher’s Masimo acquisition.
By Nick Paul Taylor • June 17, 2026 -
Courtesy of Edwards Lifesciences
CMS proposes Medicare coverage expansion for TAVR
The proposed Medicare coverage change could help Edwards Lifesciences gain market share from Medtronic and Boston Scientific, an analyst said.
By Susan Kelly • June 16, 2026 -
Courtesy of Johnson & Johnson
J&J recalls Impella controllers over hardware issues
The correction is the latest recall that J&J’s Abiomed has issued in recent years for Impella devices and controllers.
By Nick Paul Taylor • June 12, 2026 -
Permission granted by Edwards Lifesciences
Edwards gets FDA approval for surgical tricuspid valve
Built specifically to mimic the native tricuspid anatomy, the implant is intended to address an unmet patient need.
By Susan Kelly • June 3, 2026 -
Courtesy of Johnson & Johnson
J&J recalls Impella heart pumps after patient dies
Johnson & Johnson asked customers to quarantine and return affected products. A spokesperson said J&J conducted quality system audits as part of its integration of Abiomed that resulted in some field actions.
By Nick Paul Taylor • May 29, 2026
